Display options
Share it on

J Thorac Dis. 2016 Jul;8(7):1561-70. doi: 10.21037/jtd.2016.06.34.

Pure ground-glass opacity on chest computed tomography: predictive factors for invasive adenocarcinoma.

Journal of thoracic disease

Youngkyu Moon, Sook Whan Sung, Kyo Young Lee, Sung Bo Sim, Jae Kil Park

Affiliations

  1. Department of Thoracic & Cardiovascular Surgery, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea ;
  2. Department of Hospital Pathology, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea ;
  3. Department of Thoracic & Cardiovascular Surgery, St. Paul's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

PMID: 27499944 PMCID: PMC4958812 DOI: 10.21037/jtd.2016.06.34

Abstract

BACKGROUND: Pure ground-glass opacity (GGO) on computed tomography (CT) is considered a diagnostic feature of noninvasive lung adenocarcinoma. However, pure GGO can sometimes be associated with invasive adenocarcinoma (IA). The purpose of this study was to determine the predictive factors for IA when pure GGO is present.

METHODS: Between 2011 and 2014, 83 patients with persistent pure GGO on chest CT underwent surgical treatment for lung cancer. We compared the clinical, surgical, and pathological characteristics of non-IA with those of IA.

RESULTS: A total of 66 patients (79.5%) were diagnosed with non-IA and 17 patients (20.5%) were diagnosed with IA. The mean axial diameter of the GGO lesions in IA was larger than that in non-IA (1.9 vs. 1.2 cm; P<0.001). The incidence of pleural retraction was higher in IA than in non-IA (76.5% vs. 15.2%; P<0.001). Multivariate logistic regression analysis identified GGO lesion size and the presence of pleural retraction as significant predictive factors for IA.

CONCLUSIONS: Both preoperative GGO lesion size on CT and the computed-tomography or operative finding of pleural retraction are predictive factors for IA. In patients with these findings, curative lobectomy is preferable to limited resection.

Keywords: Lung cancer; adenocarcinoma; ground-glass opacity (GGO); invasive adenocarcinoma (IA)

References

  1. Radiology. 2007 Oct;245(1):267-75 - PubMed
  2. Ann Thorac Surg. 2015 Jan;99(1):218-22 - PubMed
  3. Histopathology. 2015 Jun;66(7):922-38 - PubMed
  4. J Thorac Cardiovasc Surg. 2005 May;129(5):991-6 - PubMed
  5. J Chin Med Assoc. 2013 Dec;76(12):693-7 - PubMed
  6. AJR Am J Roentgenol. 1995 Feb;164(2):503-4 - PubMed
  7. Semin Thorac Cardiovasc Surg. 2014 Autumn;26(3):210-22 - PubMed
  8. World J Surg Oncol. 2014 Dec 17;12:388 - PubMed
  9. Ann Thorac Surg. 2015 Mar;99(3):956-60 - PubMed
  10. J Thorac Oncol. 2015 Sep;10(9):1243-60 - PubMed
  11. Adv Exp Med Biol. 2016;893:1-19 - PubMed
  12. Radiology. 2008 Mar;246(3):697-722 - PubMed
  13. Eur Radiol. 2015 Sep;25(9):2532-40 - PubMed
  14. J Thorac Cardiovasc Surg. 2014 Jan;147(1):54-9 - PubMed
  15. Ann Thorac Surg. 2014 Aug;98(2):453-8 - PubMed
  16. Ann Surg Oncol. 2013 Dec;20(13):4282-8 - PubMed
  17. Chest. 2013 Oct;144(4):1291-9 - PubMed
  18. Asian Pac J Cancer Prev. 2015 ;16(5):1925-8 - PubMed
  19. Eur Radiol. 2016 Jan;26(1):43-54 - PubMed
  20. Am J Surg Pathol. 2014 Apr;38(4):448-60 - PubMed
  21. Eur Respir J. 2013 Apr;41(4):943-51 - PubMed
  22. Eur J Radiol. 2015 Apr;84(4):738-44 - PubMed
  23. AJR Am J Roentgenol. 2002 May;178(5):1053-7 - PubMed
  24. N Engl J Med. 2011 Aug 4;365(5):395-409 - PubMed
  25. Ann Thorac Surg. 2015 Sep;100(3):979-88 - PubMed
  26. J Thorac Oncol. 2011 Feb;6(2):244-85 - PubMed
  27. AJR Am J Roentgenol. 1982 Aug;139(2):311-6 - PubMed
  28. Eur J Cardiothorac Surg. 2014 Oct;46(4):632-6; discussion 636 - PubMed
  29. J Thorac Cardiovasc Surg. 2015 Sep;150(3):514-20 - PubMed

Publication Types